quantisnow
FeedTopReportsPricing
⌘K
Live feed
13:13:52·745d
SECFiling
IX Acquisition Corp. logo

IX Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (Amendment)

IXAQ· IX Acquisition Corp.
Finance
Original source

Companies

  • IXAQ
    IX Acquisition Corp.
    Finance

Related

  • SEC542d
    Amendment: SEC Form S-4/A filed by IX Acquisition Corp.
  • SEC554d
    Amendment: IX Acquisition Corp. filed SEC Form 8-K: Other Events, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
  • SEC555d
    Amendment: IX Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
  • SEC559d
    IX Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
  • SEC570d
    Amendment: SEC Form S-4/A filed by IX Acquisition Corp.
  • SEC573d
    IX Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
  • SEC577d
    SEC Form DEF 14A filed by IX Acquisition Corp.
  • SEC577d
    IX Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022